Cargando…

Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients

OBJECTIVE: To assess serum 25-hydroxyvitamin D3 (25(OH)D3), fibroblast growth factor 23 (FGF23), and C1q/tumor necrosis factor-related protein-3 (CTRP3) levels in nondialysis chronic kidney disease (CKD) patients and their relationship with coronary artery calcification (CAC). METHODS: One hundred a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuanjie, Hu, Zhijuan, Liu, Yu, Qin, Congcong, Chen, Xing, Shi, Yanan, Wang, Lijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259302/ https://www.ncbi.nlm.nih.gov/pubmed/37293793 http://dx.doi.org/10.1080/0886022X.2023.2220412

Ejemplares similares

Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease
por: Nam, Ki Heon, et al.
Publicado: (2018)

Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
por: Hamano, Takayuki, et al.
Publicado: (2013)

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses
por: Block, Geoffrey A, et al.
Publicado: (2019)

25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up
por: Ishigami, Junichi, et al.
Publicado: (2021)

Loss of nighttime blood pressure dipping as a risk factor for coronary artery calcification in nondialysis chronic kidney disease
por: Choi, Hoon Young, et al.
Publicado: (2017)

Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
por: Bishop, Charles W., et al.
Publicado: (2022)

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
por: Scialla, Julia J., et al.
Publicado: (2013)

Maternal and Neonatal 3-epi-25-hydroxyvitamin D Concentration and Factors Influencing Their Concentrations
por: Mao, Di, et al.
Publicado: (2021)

The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers
por: NasrAllah, Mohamed M., et al.
Publicado: (2013)

Resistant Hypertension in Nondialysis Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2013)

MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23
por: Zheng, Shouhua, et al.
Publicado: (2016)

Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients
por: Muzasti, Riri Andri, et al.
Publicado: (2021)

The First Convergent Synthesis of 23,23-Difluoro-25-hydroxyvitamin D(3) and Its 24-Hydroxy Derivatives: Preliminary Assessment of Biological Activities
por: Mototani, Sayuri, et al.
Publicado: (2022)

Influencing factors on serum 25-hydroxyvitamin D(3) levels in Japanese chronic hepatitis C patients
por: Atsukawa, Masanori, et al.
Publicado: (2015)

Treatment of an Intramammary Bacterial Infection with 25-Hydroxyvitamin D(3)
por: Lippolis, John D., et al.
Publicado: (2011)

25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) induces ectopic calcification
por: Yimamu, Yilimulati, et al.
Publicado: (2022)

Serum 25-hydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) concentrations in adult dogs are more substantially increased by oral supplementation of 25-hydroxyvitamin D(3) than by vitamin D(3)
por: Young, Lauren R., et al.
Publicado: (2017)

Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease
por: Kerr, Jasmine D, et al.
Publicado: (2013)

Machine Learning for the Prevalence and Severity of Coronary Artery Calcification in Nondialysis Chronic Kidney Disease Patients: A Chinese Large Cohort Study
por: Zhu, Haitao, et al.
Publicado: (2022)

Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
por: Chailurkit, La-or, et al.
Publicado: (2016)

Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
por: Yusuf, Jamal, et al.
Publicado: (2018)

Association between Serum 25-Hydroxyvitamin D and Abdominal Aortic Calcification: A Large Cross-Sectional Study
por: Liu, Tao, et al.
Publicado: (2023)

The genetic determinants of circulating C3-epimers of 25-hydroxyvitamin D
por: Torugsa, Sirikunya, et al.
Publicado: (2018)

Use of 25-hydroxyvitamin D(3) in diets for sows: A review
por: Zhang, Lianhua, et al.
Publicado: (2021)

Gene-Regulatory Potential of 25-Hydroxyvitamin D(3) and D(2)
por: Hanel, Andrea, et al.
Publicado: (2022)

25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) Promote the Differentiation of Human Subcutaneous Preadipocytes
por: Nimitphong, Hataikarn, et al.
Publicado: (2012)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation
por: Mazahery, Hajar, et al.
Publicado: (2015)

25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2016)

Are Serum 25-Hydroxyvitamin D Deficiency and Insufficiency Risk Factors for the Incidence of Dynapenia?
por: Delinocente, Maicon Luís Bicigo, et al.
Publicado: (2022)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification
por: Kumar, Tarun, et al.
Publicado: (2022)

Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D(3)
por: Nelson, Corwin D., et al.
Publicado: (2011)

The Association of 25-Hydroxyvitamin D(3) and D(2) with Behavioural Problems in Childhood
por: Tolppanen, Anna-Maija, et al.
Publicado: (2012)

Serum 25-hydroxyvitamin D3 concentration in Iranian patients with Parkinson's disease
por: Moghaddasi, Mehdi, et al.
Publicado: (2013)

Serum 25–Hydroxyvitamin D(3) and Mammography Density among Mexican Women
por: Amadou, Amina, et al.
Publicado: (2016)

Association between urinary chloride excretion and progression of coronary artery calcification in patients with nondialysis chronic kidney disease: results from the KNOW-CKD study
por: Suh, Sang Heon, et al.
Publicado: (2023)

Sodium thiosulfate for the treatment of warfarin-induced calciphylaxis in a nondialysis patient
por: Carrell, Emily J., et al.
Publicado: (2015)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients
por: Brito, Gysllene M. C., et al.
Publicado: (2021)

Relationship between 25-hydroxyvitamin D levels and inflammatory factors in children with asthma attack
por: Wang, Shang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_96kk1p190thlannjql12nri276